These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 18200437)

  • 1. Driving-related risks and impact of methylphenidate treatment on driving in adults with attention-deficit/hyperactivity disorder (ADHD).
    Sobanski E; Sabljic D; Alm B; Skopp G; Kettler N; Mattern R; Strohbeck-Kühner P
    J Neural Transm (Vienna); 2008; 115(2):347-56. PubMed ID: 18200437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of stimulant medication on driving performance of young adults with attention-deficit hyperactivity disorder: a preliminary double-blind placebo controlled trial.
    Cox DJ; Merkel RL; Kovatchev B; Seward R
    J Nerv Ment Dis; 2000 Apr; 188(4):230-4. PubMed ID: 10790000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ADHD, methylphenidate and driving: does some legislation endanger public health?
    Verster JC; Cox DJ
    J Psychopharmacol; 2008 May; 22(3):227-9. PubMed ID: 18541623
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-acting methylphenidate reduces collision rates of young adult drivers with attention-deficit/hyperactivity disorder.
    Cox DJ; Davis M; Mikami AY; Singh H; Merkel RL; Burket R
    J Clin Psychopharmacol; 2012 Apr; 32(2):225-30. PubMed ID: 22367664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
    Cox DJ; Merkel RL; Moore M; Thorndike F; Muller C; Kovatchev B
    Pediatrics; 2006 Sep; 118(3):e704-10. PubMed ID: 16950962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of psychiatric comorbidities with the risk of transport accidents in ADHD and MPH.
    Liu YC; Chen VC; Yang YH; Chen YL; Gossop M
    Epidemiol Psychiatr Sci; 2021 Feb; 30():e14. PubMed ID: 33583471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled-release methylphenidate improves attention during on-road driving by adolescents with attention-deficit/hyperactivity disorder.
    Cox DJ; Humphrey JW; Merkel RL; Penberthy JK; Kovatchev B
    J Am Board Fam Pract; 2004; 17(4):235-9. PubMed ID: 15243010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of two doses of methylphenidate on simulator driving performance in adults with attention deficit hyperactivity disorder.
    Barkley RA; Murphy KR; O'Connell T; Connor DF
    J Safety Res; 2005; 36(2):121-31. PubMed ID: 15896352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylphenidate significantly reduces lapses of attention during on-road highway driving in patients with ADHD.
    Verster JC; Roth T
    J Clin Psychopharmacol; 2014 Oct; 34(5):633-6. PubMed ID: 24978156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of long-acting OROS methylphenidate on routine driving in young adults with attention-deficit/hyperactivity disorder.
    Cox DJ; Mikami AY; Cox BS; Coleman MT; Mahmood A; Sood A; Moore M; Burket R; Merkel RL
    Arch Pediatr Adolesc Med; 2008 Aug; 162(8):793-4. PubMed ID: 18678816
    [No Abstract]   [Full Text] [Related]  

  • 11. [Graphomotor functions in children with attention deficit hyperactivity disorder (ADHD)].
    Stasik D; Tucha O; Tucha L; Walitza S; Lange KW
    Psychiatr Pol; 2009; 43(2):183-92. PubMed ID: 19697788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of driving risks and impairments associated with attention-deficit/hyperactivity disorder and the effects of stimulant medication on driving performance.
    Barkley RA; Cox D
    J Safety Res; 2007; 38(1):113-28. PubMed ID: 17303170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Driving in young adults with attention deficit hyperactivity disorder: knowledge, performance, adverse outcomes, and the role of executive functioning.
    Barkley RA; Murphy KR; Dupaul GI; Bush T
    J Int Neuropsychol Soc; 2002 Jul; 8(5):655-72. PubMed ID: 12164675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Attention Deficit Hyperactivity Disorder (ADHD) and road traffic - special considerations for the treatment of adolescents with ADHD].
    Ludolph AG; Kölch M; Plener PL; Schulze UM; Spröber N; Fegert JM
    Z Kinder Jugendpsychiatr Psychother; 2009 Sep; 37(5):405-11. PubMed ID: 19739058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rebound effects with long-acting amphetamine or methylphenidate stimulant medication preparations among adolescent male drivers with attention-deficit/hyperactivity disorder.
    Cox DJ; Moore M; Burket R; Merkel RL; Mikami AY; Kovatchev B
    J Child Adolesc Psychopharmacol; 2008 Feb; 18(1):1-10. PubMed ID: 18294083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Supervised off-label prescribing of methylphenidate in adult ADHD].
    Carton L; Dondaine T; Deheul S; Marquié C; Brigadeau F; Amad A; Devos D; Danel T; Bordet R; Cottencin O; Gautier S; Ménard O
    Encephale; 2019 Feb; 45(1):74-81. PubMed ID: 30122296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel multidomain computerized cognitive assessment for attention-deficit hyperactivity disorder: evidence for widespread and circumscribed cognitive deficits.
    Leitner Y; Doniger GM; Barak R; Simon ES; Hausdorff JM
    J Child Neurol; 2007 Mar; 22(3):264-76. PubMed ID: 17621495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurocognitive effects of methylphenidate in adult attention-deficit/hyperactivity disorder.
    Turner DC; Blackwell AD; Dowson JH; McLean A; Sahakian BJ
    Psychopharmacology (Berl); 2005 Mar; 178(2-3):286-95. PubMed ID: 15338103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do Pharmaceuticals Improve Driving in Individuals with ADHD? A Review of the Literature and Evidence for Clinical Practice.
    Surman CBH; Fried R; Rhodewalt L; Boland H
    CNS Drugs; 2017 Oct; 31(10):857-866. PubMed ID: 29052031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylphenidate significantly improves driving performance of adults with attention-deficit hyperactivity disorder: a randomized crossover trial.
    Verster JC; Bekker EM; de Roos M; Minova A; Eijken EJ; Kooij JJ; Buitelaar JK; Kenemans JL; Verbaten MN; Olivier B; Volkerts ER
    J Psychopharmacol; 2008 May; 22(3):230-7. PubMed ID: 18308788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.